Navigation Links
Unilife Hosts White House Business Council Meeting
Date:6/17/2011

YORK, Pa., June 17, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today hosted Kathleen Merrigan, the Deputy Secretary of the U.S. Department of Agriculture, for a White House Business Council roundtable discussion with local business leaders at its facility in York, Pennsylvania.

The White House established the White House Business Council (WHBC) under the direction of President Obama. The Winning the Future Roundtables with American Business tour now being conducted by the WHBC is enabling the Obama Administration (the "Administration") to hear directly from U.S. business leaders about their ideas for how to continue to grow the economy, put Americans back to work, and win the future.

The WHBC meeting hosted by Unilife with local business leaders in York was amongst the first of more than 100 Council roundtables that will be held by the Administration across all 50 U.S. states by the end of the year.

Unilife's Chief Executive Officer Mr. Alan Shortall welcomed the Agriculture Deputy Secretary, Pennsylvania State Director of the U.S. Department of Agriculture Tom Williams, other members of the White House Business Council and members of the York business community to the WHBC Roundtable Discussion.

"As an emerging leader for advanced drug delivery systems with a new and fast-growing presence in Pennsylvania, Unilife is committed to supporting U.S. programs that can accelerate opportunities for home-grown innovation, attract international investment and create jobs in the industries of tomorrow," Mr. Shortall said.

"Unilife was honored to be invited to host the Agriculture Deputy Secretary and the White House Business Council to discuss these key important matters with members of the York business community."

In October last year, the U.S. Department of Agriculture (USDA) agreed to guarantee $10 million of an $18 million mortgage Unilife obtained to support construction of its new $32 million global headquarters and manufacturing facility in York, Pennsylvania.

About Unilife CorporationUnilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines. Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world's first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs.  For more information on Unilife, please visit www.unilife.com.

This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

General: UNIS-G Investor Contacts (US):Investor Contacts (Australia)Todd Fromer / Garth Russell

Stuart Fine

Jeff CarterKCSA Strategic Communications

Carpe DM Inc

Unilife CorporationP: + 1 212-682-6300

P: + 1 908 469 1788

P: + 61 2 8346 6500
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
2. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
3. Unilife Announces Financial Results for the Third Quarter of Fiscal 2011
4. Unilife Corporation to Announce Financial Results for Fiscal 2011 Third Quarter on Monday, May 16, 2011
5. Unilife to Present at the 36th Annual Deutsche Bank Health Care Conference on Monday, May 2, 2011 in Boston
6. Unilife Announces Chairmans Letter to Shareholders
7. Unilife Realigns Operations to Drive Sales and Support Commercial Production of Unifill Syringes
8. Unilife Commences Initial Production of Unifill Prefilled Syringe
9. Unilife COO Makes Open Market Purchase of Approximately $250,000 in Companys Publicly Traded Shares
10. Unilife CEO Makes Open Market Purchase of A$500,000 in Companys Publicly Traded Shares
11. Unilife on Schedule to Fill Initial Orders for Unifill Syringe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Providing broad access to ... opposition, but there is a better way to address this problem. , That was ... Pharmacy, Public Policy and Economics at the University of Southern California, who served as ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs ... has kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which ... Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” ... next project in the company’s esteemed VISION House demonstration project series. Manifesting the concept ... amount of resources they need to live affordably and abundantly without unduly taxing the ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , an ... an active lifestyle company that provides Human Performance Training and education to tactical ... first responders, military officers and others in service through the development and conditioning ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern ... Regional Primary Care Spring Symposium on April 1, 2017 in Santa Rosa. This ... physicians and healthcare providers an opportunity to learn about cutting edge treatments, to ...
Breaking Medicine News(10 mins):